Human Albumin (European Foundation for Study of Chronic Liver Failure)
人血白蛋白 (European Foundation for Study of Chronic Liver Failure)
Report date: 2024/03/26 18:00:53
Base Information
Drug NameHuman Albumin (European Foundation for Study of Chronic Liver Failure)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[5]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEuropean Foundation For Chronic Liver Failure
China Registration ClassN/A
Develop Information
Active CompaniesEuropean Foundation For Chronic Liver Failure
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A